NovaBay Pharmaceuticals (NBY)
Create an AlertNovaBay Pharmaceuticals News
NovaBay Pharmaceuticals Mid-Year Clinical Update
GlobeNewswire Jun 11Clinical Results From Three Auriclosene Phase 2 Trials Expected in Second Half of This Year
RedChip Issues Research Profile on NovaBay Pharmaceuticals
GlobeNewswire Jun 6ORLANDO, Fla. -- RedChip Companies, Inc., today announced it has issued a research profile on NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet ...
InPlay: NovaBay Pharma and Virbac enter into a collaboration and license agreement for animal health
May 28NovaBay Pharmaceuticals and Virbac Enter Into a Collaboration and License Agreement for Animal Health
GlobeNewswire May 28Virbac Exercises Option to Develop Auriclosene for Use in Global Veterinary Markets
NovaBay Pharmaceuticals Reports First Quarter Financial Results and Clinical and Business Update
noodls May 2Press Releases Clinical Results from Three Aganocide® Trials Expected in Second Half of 2013 EMERYVILLE, CA - May 2, 2013 NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biotechnology company ...
NovaBay Pharmaceuticals (NBY) Posts Q1 Loss of 11c/Share
Street Insider May 2RedChip Emerging Growth Showcase Takes Place May 1
GlobeNewswire Apr 23ORLANDO, Fla. -- RedChip Companies, Inc. ("RedChip"), an international small-cap research, investor relations, and media company, today announced the guest lineup for its Emerging Growth Showcase ...
"The RedChip Money Report" Now Airing Nationally on WGN
GlobeNewswire Apr 12ORLANDO, Fla. -- RedChip Companies, Inc. ("RedChip"), an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report"(TM) ...
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NBY | 1.33 | +0.00 | +0.00% | 49.65M |
